Drug intelligence / Profile preview

dexamethasone + ibuprofen

Development stage
Unknown
Lead developer
WellSpan Health
Modality
Small Molecules
Administration
Oral
01

Overview

Dexamethasone + ibuprofen is a combination treatment regimen being investigated by WellSpan Health for the management of acute osteoarthritis pain in patients presenting to the emergency department. Dexamethasone is a potent synthetic glucocorticoid that acts as an anti-inflammatory agent by binding to the glucocorticoid receptor, thereby inhibiting the expression of pro-inflammatory genes and potentially exerting chondroprotective effects. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes (COX-1 and COX-2) to reduce prostaglandin synthesis. This specific regimen, evaluated in the NCT06603662 clinical trial, involves a single 10 mg oral dose of dexamethasone administered alongside a 5-day course of ibuprofen to assess whether the addition of a systemic steroid provides superior analgesic relief compared to NSAID monotherapy for acute flares of osteoarthritis.

Other names
dexamethasoneibuprofenSystemic Oral Glucocorticoids for Acute Osteoarthritis Pain
02

Targets

GR (Glucocorticoid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on dexamethasone + ibuprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + ibuprofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call